SCHEMBL1385833

SCHEMBL1385833

c1ccc(COc2nn(CCN3CCCC3)cc2-c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.48
HRH3 Q9Y5N1 6/20 0.47
KDM4E B2RXH2 4/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MCHR1 Q99705 3/20 0.45
ALDH1A1 P00352 4/20 0.44
HTT P42858 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
NPY1R P25929 1/20 0.44
HRH1 P35367 1/20 0.42
KCNH2 Q12809 1/20 0.42
MEN1 O00255 1/20 0.42
PKM P14618 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2583849 0.99 LTA4H (0.47) LTA4HHRH3KDM4ENPC1RAB9A
SCHEMBL2577848 0.99 LTA4H (0.47) LTA4HHRH3KDM4ENPC1RAB9A
SCHEMBL4045002 0.99 LTA4H (0.47) LTA4HHRH3KDM4ENPC1RAB9A
Oxalic Acid SCHEMBL2582750 0.94 KDM4E (0.55) HRH3KDM4ENPC1RAB9ASMN1; SMN2
Oxalic Acid SCHEMBL2575764 0.93 NPC1 (0.56) HRH3KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL2576788 0.92 PDE10A (0.45) LTA4HHRH3KDM4ENPC1RAB9A
SCHEMBL2575882 0.91 CNR1 (0.44) LTA4HHRH3KDM4ENPC1RAB9A
SCHEMBL2582255 0.91 KCNH2 (0.43) LTA4HHRH3KDM4ENPC1RAB9A
SCHEMBL2580788 0.91 LTA4H (0.43) LTA4HHRH3KDM4ENPC1RAB9A
SCHEMBL2579448 0.91 BCHE (0.45) LTA4HHRH3KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4833078-B2 2011-12-07 JP claimed
EP-1689720-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS Aventis Pharma S.A. (FR) 2006-08-16 EP claimed
WO-2005051917-A9 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2005-09-29 WO claimed
WO-2005051917-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA S.A. (FR) 2005-06-09 WO claimed
EP-1689720-B1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2009-04-15 EP disclosed
EP-1689720-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS Aventis Pharma S.A. (FR) 2006-08-16 EP disclosed
WO-2005051917-A9 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2005-09-29 WO disclosed
WO-2005051917-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA S.A. (FR) 2005-06-09 WO disclosed